End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
545 KRW | -6.84% | -.--% | -54.77% |
Apr. 16 | Wellbiotec Co., Ltd.(KOSE:A010600) dropped from S&P Global BMI Index | CI |
Apr. 08 | Wellbiotec Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 158B 116M | Sales 2023 | 72.13B 52.73M | Capitalization | 110B 80.09M |
---|---|---|---|---|---|
Net income 2022 | -20.88B -15.26M | Net income 2023 | -64.91B -47.45M | EV / Sales 2022 | 0.39 x |
Net cash position 2022 | 8.47B 6.19M | Net cash position 2023 | 13.12B 9.59M | EV / Sales 2023 | 1.34 x |
P/E ratio 2022 |
-3.28
x | P/E ratio 2023 |
-1.47
x | Employees | 29 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.31% |
1 day | -6.84% | ||
3 months | -39.91% | ||
6 months | -63.84% | ||
Current year | -54.77% |
Managers | Title | Age | Since |
---|---|---|---|
Se-Hyun Gu
CEO | Chief Executive Officer | 50 | 18-07-16 |
Hang-Seok Kim
AUD | Comptroller/Controller/Auditor | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Se-Hyun Gu
CEO | Chief Executive Officer | 50 | 18-07-16 |
Tae-Kyu Park
BRD | Director/Board Member | 57 | 18-11-14 |
Chun-Jae Park
BRD | Director/Board Member | 52 | - |
1st Jan change | Capi. | |
---|---|---|
-54.77% | 36.18M | |
-4.51% | 2.53B | |
-20.90% | 591M | |
+3.45% | 509M | |
+12.84% | 452M | |
+23.20% | 293M | |
-9.32% | 269M | |
+32.30% | 232M | |
+1.50% | 133M | |
-13.46% | 128M |
- Stock Market
- Equities
- A010600 Stock